Nutrien Ltd. (NYSE: NTR) is a Basic Materials company in the Agricultural Inputs industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 13.43 | EPS (ttm) | 4.91 | Insider Own | 0.26% | Shs Outstand | 480.02M | Perf Week | -2.14% |
| Market Cap | 31.66B | Forward P/E | 12.78 | EPS next Y | 5.16 | Insider Trans | - | Shs Float | 479.30M | Perf Month | 1.38% |
| Enterprise Value | 44.87B | PEG | - | EPS next Q | - | Inst Own | - | Short Float | 1.16% | Perf Quarter | -12.31% |
| Income | 2.39B | P/S | 1.14 | EPS this Y | 12.86% | Inst Trans | - | Short Ratio | 1.95 | Perf Half Y | -4.25% |
| Sales | 27.83B | P/B | 1.25 | EPS next Y | -6.88% | ROA | 4.41% | Short Interest | 5.57M | Perf YTD | 6.87% |
| Book/sh | 52.65 | P/C | 40.59 | EPS next 5Y | -1.75% | ROE | 9.48% | 52W High | 86.61 -22.73% | Perf Year | 11.19% |
| Cash/sh | 1.62 | P/FCF | 14.86 | EPS past 3/5Y | -29.66% 41.02% | ROIC | 6.65% | 52W Low | 53.80 24.38% | Perf 3Y | -1.92% |
| Dividend Est. | 2.20 (3.29%) | EV/EBITDA | 7.10 | Sales past 3/5Y | -10.80% 5.16% | Gross Margin | 31.16% | Volatility | 2.84% 2.36% | Perf 5Y | 11.04% |
| Dividend TTM | 2.19 (3.27%) | EV/Sales | 1.61 | EPS Y/Y TTM | 261.03% | Oper. Margin | 14.15% | ATR (14) | 1.83 | Perf 10Y | - |
| Dividend Ex-Date | Jun 30, 2026 | Quick Ratio | 0.59 | Sales Y/Y TTM | 7.16% | Profit Margin | 8.58% | RSI (14) | 45.04 | Recom | 2.48 |
| Dividend Gr. 3/5Y | 4.32% 3.91% | Current Ratio | 1.24 | EPS Q/Q | 363.64% | SMA20 | -2.49% | Beta | 0.62 | Target Price | 80.43 |
| Payout | 44.21% | Debt/Eq | 0.51 | Sales Q/Q | 18.55% | SMA50 | -0.88% | Rel Volume | 0.81 | Prev Close | 65.96 |
| Employees | 25,100 | LT Debt/Eq | 0.44 | Earnings | Aug 05 | SMA200 | -1.57% | Avg Volume | 2.78M | Price | 66.92 |
| IPO Date | Jan 02, 2018 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -3.44% 7.28% | Net Debt/EBITDA | 2.09 | Volume | 2,245,175 | Change | 1.46% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-28-26 | Reiterated | BNP Paribas | $80 | |
| Jul-16-26 | Downgrade | Jefferies | Buy → Hold | $66 → $63 |
| Jun-30-26 | Upgrade | Scotiabank | Sector Perform → Sector Outperform | $133 → $80 |
| Jun-10-26 | Reiterated | Berenberg Bank | $66 → $65 | |
| May-05-26 | Reiterated | Raymond James | Market Perform | $68 → $90 |
| Apr-27-26 | Upgrade | Barclays | Equal Weight → Overweight | $95 → $85 |
| Mar-26-26 | Downgrade | UBS | Neutral → Sell | |
| Mar-13-26 | Upgrade | Wells Fargo | Equal Weight → Overweight | $50 → $100 |
| Mar-12-26 | Upgrade | Jefferies | Hold → Buy | |
| Jan-20-26 | Reiterated | RBC Capital | Outperform | $60 → $75 |
Nutrien Ltd., a company established in 2017 and based in Saskatoon, Canada, functions as a principal supplier of essential agricultural resources and associated services. The firm furnishes vital crop inputs, including various fertilizer compounds like potash, nitrogen, phosphate, and sulfate, in addition to offering financial solutions to its clientele. Its operations involve the extensive distribution of crop-related products such as nutrients, protection agents, seeds, and general merchandise. This is facilitated through a vast network of nearly 2,000 retail establishments situated across the United States, Canada, South America, and Australia. Beyond its retail footprint, Nutrien also engages directly with agricultural producers, delivering personalized services through its numerous farm centers located throughout North America, South America, and Australia.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 27,831 | 26,885 | 25,972 | 29,056 | 37,884 | 27,712 | 20,908 | 20,084 | 19,636 | |
| Cost of Goods Sold Incl. D&A | 19,158 | 18,538 | 18,442 | 20,582 | 22,460 | 18,303 | 15,669 | 14,582 | 14,244 | |
| Gross Profit | 8,673 | 8,347 | 7,530 | 8,474 | 15,424 | 9,409 | 5,239 | 5,502 | 5,392 | |
| Selling, General and Administrative Excl. Other | 4,228 | 4,104 | 4,173 | 4,064 | 4,092 | 3,821 | 3,311 | 3,013 | 2,876 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 508 | 374 | 406 | 550 | 523 | 807 | 1,026 | 627 | 2,102 | |
| Operating Income | 3,937 | 3,869 | 2,951 | 3,860 | 10,809 | 4,781 | 902 | 1,862 | 414 | |
| Interest Expense | 726 | 729 | 661 | 804 | 529 | 475 | 521 | 559 | 555 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -25 | -91 | -1,154 | -1,104 | -34 | -138 | 1 | 5 | 17 | |
| Net Income Before Taxes | 3,186 | 3,049 | 1,136 | 1,952 | 10,246 | 4,168 | 382 | 1,308 | -124 | |
| Income Taxes | 769 | 752 | 436 | 670 | 2,559 | 989 | -77 | 316 | -93 | |
| Consolidated Net Income | 2,387 | 2,267 | 674 | 1,258 | 7,660 | 3,153 | 459 | 992 | 3,573 | |
| Net Income From Continuing Operations | 2,417 | 2,297 | 700 | 1,282 | 7,687 | 3,179 | 459 | 992 | -31 | |
| Net Income | 2,387 | 2,267 | 674 | 1,258 | 7,660 | 3,153 | 459 | 992 | 3,573 | |
| EPS (Recurring) | 4.92 | 4.74 | 1.36 | 2.53 | 13.66 | 5.49 | 0.85 | 1.74 | 5.76 | |
| EPS (Basic, Before Extraordinaries) | 4.92 | 4.74 | 1.36 | 2.53 | 13.66 | 5.49 | 0.85 | 1.74 | 5.76 | |
| EPS (Diluted) | 4.91 | 4.74 | 1.36 | 2.53 | 13.62 | 5.47 | 0.85 | 1.74 | 5.72 | |
| EBITDA | 6,316 | 6,147 | 4,212 | 4,885 | 12,779 | 6,582 | 2,892 | 3,666 | 2,023 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 13.63 | 13.02 | 32.90 | 22.26 | 5.36 | 13.75 | 56.66 | 27.53 | 8.22 | |
| Price To Sales Ratio | 1.16 | 1.12 | 0.85 | 0.96 | 1.04 | 1.55 | 1.31 | 1.39 | 1.48 | |
| Gross Margin | 31.16 | 31.05 | 28.99 | 29.16 | 40.71 | 33.95 | 25.06 | 27.39 | 27.46 | |
| Operating Margin | 14.15 | 14.39 | 11.36 | 13.28 | 28.53 | 17.25 | 4.31 | 9.27 | 2.11 | |
| Net Margin | 8.58 | 8.43 | 2.60 | 4.33 | 20.22 | 11.38 | 2.20 | 4.94 | 18.20 | |
| Shares Outstanding | 481 | 486 | 494 | 496 | 538 | 570 | 570 | 582 | 620 | |
| Market Capitalization | 32,189 | 29,996 | 22,107 | 27,940 | 39,290 | 42,864 | 27,451 | 27,884 | 29,140 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Sherman Jerome F | Director | Aug 31 '07 | Buy | 1.04 | 2,000 | 2,080 | 27,000 | Sep 11 |
| Akre David A | Vice Chairman/Co-CEO | Aug 31 '07 | Buy | 1.14 | 1,000 | 1,140 | 102,903 | Sep 04 |
| Akre David A | Vice Chairman/Co-CEO | Aug 30 '07 | Buy | 1.10 | 3,100 | 3,419 | 101,903 | Aug 30 |
| Akre David A | Vice Chairman/Co-Chief Exe Ofr | Apr 05 '07 | Buy | 2.42 | 7,500 | 18,134 | 99,803 | Apr 05 |
| Wirth Michael I | other: Former CFO | Feb 27 '07 | Sale | 3.25 | 33,990 | 110,475 | 0 | Feb 28 |
| Wirth Michael I | other: Former CFO | Feb 14 '07 | Sale | 3.32 | 25,000 | 82,998 | 50,530 | Feb 15 |
| Wirth Michael I | CFO, Exec. VP, Sec. & Treas./ | Mar 22 '06 | Buy | 4.47 | 1,000 | 4,470 | 75,530 | May 16 |
| Sherman Jerome F | Director | Mar 23 '06 | Buy | 4.50 | 3,000 | 13,500 | 15,000 | Apr 17 |
| Fierro Joseph V | COO-NYMC/ | Mar 29 '06 | Buy | 4.91 | 7,500 | 36,832 | 920,680 | Apr 04 |
| Fierro Joseph V | COO-NYMC/ | Mar 28 '06 | Buy | 4.73 | 5,000 | 23,628 | 918,180 | Apr 04 |
| Akre David A | Co-Chief Executive Officer | Dec 06 '05 | Buy | 5.65 | 5,000 | 28,243 | 92,303 | Dec 06 |
| Sherman Jerome F | Director | Sep 06 '05 | Buy | 8.22 | 2,000 | 16,440 | 9,500 | Sep 15 |
| Fierro Joseph V | COO - The N.Y. Mort. Co., LLC | Jun 29 '04 | Buy | 1.06 | 945,000 | 1,004,400 | 885,100 | Feb 11 |
| Sherman Jerome F | Director | Sep 08 '04 | Buy | 9.60 | 2,000 | 19,200 | 4,500 | Sep 08 |
| Wirth Michael I | CFO, Exec. VP, Sec. & Treas. | Jun 24 '04 | Buy | 8.75 | 100 | 875 | 100 | Jun 25 |